CXA-10 Study in Subjects With Pulmonary Arterial Hypertension
Status:
Terminated
Trial end date:
2020-08-12
Target enrollment:
Participant gender:
Summary
This is a Phase 2, multicenter, open-label extension (OLE) of study CXA-10-301, to evaluate
the long term safety and efficacy of daily dosing of CXA-10.
Phase:
Phase 2
Details
Lead Sponsor:
Complexa, Inc.
Collaborators:
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) Innovative Analytics Medpace, Inc.